Skip to main content
AEMD logo

AEMD · Aethlon Medical Inc · Metrics

Track AEMD — free
$4.84 -0.27 (-5.28%) Play latest call Q3 2026 earnings call transcript
Market Cap
$7.78M
Shares
1.61M
Volume · Nov 19 20.26K Avg daily vol (3M) 2.52M

AEMD metrics

54 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.84
Market cap
$7.78M

Price action

23 metrics
Price change (1W)
-7.6%
Price change (30D)
-1.0%
Price change (3M)
+83.8%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
$24.20
52-week low
$1.43
Change from 52-week high
-78.9%
Change from 52-week low
+257.3%
Annualized volatility
692.8%
Annualized volatility (3M)
743.6%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
—
RSI (14D)
45.1
Price vs SMA 50
-4.0%
Price vs SMA 200
—
Avg volume (3M)
2.52M
Relative volume
0.0
Average dollar volume
$12.66M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
1.61M

Valuation

12 metrics
P / E (TTM)
3.5
Trailing earnings · reciprocal yield 28.4%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
1.4
reciprocal yield 73.7%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-98.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$8.25M
Net income (TTM)
−$8.07M
Trailing 12 months
Diluted EPS (TTM)
$1.45
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$100.00
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$15.56

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1,167.3%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-133.3%
Return on assets
-110.0%
Debt / equity
—
Current ratio
5.4
EBITDA (TTM)
−$7.93M
Free cash flow (TTM)
—
Quick ratio
5.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$6.49M
Latest balance sheet
Cash & equivalents
$6.49M
Total assets
$7.33M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$7.26M
Capital expenditures (TTM)
$15,019
R&D (TTM)
$2.12M
SG&A (TTM)
—
Stock compensation (TTM)
$233,663
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
17
13F filer change QoQ
0
Institutional ownership
32.1%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
59.7%
Private-fund adviser ownership
42.5%
Active holders' share change QoQ
+917.2%
Holder tenure
1.4
Price vs estimated holder cost
-37.0%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.2%

Short interest

3 metrics
Short interest
2.7%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
60 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 882291 CUSIP 00808Y703 13F (30d) 16 filings 16 filers Visit website Investor relations